Medication Guide - 3/28/2022

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Rebetol Ribavirin CAPSULE;ORAL 020903 MERCK SHARP DOHME 03/16/2022 Rebetol Ribavirin SOLUTION;ORAL 021546 SCHERING 03/16/2022 Rinvoq Upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675 ABBVIE INC 03/16/2022 Myfortic Mycophenolic Sodium TABLET, DELAYED RELEASE;ORAL 050791 NOVARTIS 03/15/2022 Dayvigo Lemborexant TABLET;ORAL 212028 EISAI INC 03/11/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA